Total Credits: 1.0 including 1.0 AOA Category 1-A, 1.0 AMA PRA Category 1
Respiratory Syncytial Virus (RSV): Recognizing and Mitigating Risk in Vulnerable Adults
Stefan Gravenstein, MD, MPH
Faculty and Planning Committee Disclosures
Dr. Stefan Gravenstein reported the following relevant financial relationships with ineligible companies:
Dr. Gravenstein does not discuss off-label uses of any products.
All relevant financial relationships have been mitigated. No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. The AOMA designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Arizona Osteopathic Medical Association (AOMA) designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W Camelback Rd, Suite 105, Phoenix, AZ 85015 or by email to email@example.com.
|Respiratory Syncytial Virus (RSV): Recognizing and Mitigating Risk in Vulnerable Adults - Handout|
Dr. Stefan Gravenstein is a geriatrician that has served as director or chief of geriatrics in three academic institutions, now the Director, Division of Geriatrics and Palliative Medicine at the Alpert Medical School of Brown University. Dr. Gravenstein has a long-standing interest in immunity, inflammation, cardiovascular outcomes and aging especially in the context of infection, vaccines and the long-term care setting, and the topic of the majority of his publications.
Dr. Gravenstein discloses the following:
He has received research support from: Seqirus, Sanofi, Pfizer
He is on the Advisory Board for Novavax, Sanofi, Pfizer, VaxArt, Janssen
He is on the speakers’ Bureau for Seqirus, GSK
He is on the Data and Safety Monitoring Board for Longevoron, SciClone
Please wait ...